FGF2-STAB as a key component for the cell-cultured meat media
Project goals
1) To receive feedback on the FGF2-STAB technology to be used specifically for the cell-cultured meat industry 2) To design FGF2-STAB with parameters meeting cell-based meat industry regulatory standards 3) To actively build connections to companies aiming to succeed in the cell-cultured meat market 4) To define a clear go-to-market strategy for our FGF2-STAB in the cell-cultured meat market
Keywords
BiotechnologyFibroblast growth factor 2, FGF2Cell-cultured meat mediaCultivated meat
Public support
Provider
Technology Agency of the Czech Republic
Programme
—
Call for proposals
3.VS GAMA 2 (STA02021TP030)
Main participants
Enantis s.r.o.
Contest type
VS - Public tender
Contract ID
TP03020019 - Smlouva o poskytnutí podpory
Alternative language
Project name in Czech
FGF2-STAB jako klíčová komponenta média pro kultivaci masa
Annotation in Czech
1) Získat zpětnou vazbu na využití FGF2-STAB pro trh kultivovaného masa 2) Identifikace parametrů FGF2-STAB splňujících regulatorní standardy požadované pro výrobu kultivovaného masa 3) Vytvořit aktivní vazby na firmy, které se chtějí prosadit na trhu výroby kultivovaného masa 4) Vytvořit jasnou strategii pro vstup našeho FGF2-STAB na trh kultivovaného masa
Scientific branches
R&D category
VV - Exeperimental development
OECD FORD - main branch
20901 - Industrial biotechnology
OECD FORD - secondary branch
30403 - Technologies involving identifying the functioning of DNA, proteins and enzymes and how they influence the onset of disease and maintenance of well-being (gene-based diagnostics and therapeutic interventions [pharmacogenomics, gene-based therapeutics])
OECD FORD - another secondary branch
40401 - Agricultural biotechnology and food biotechnology
EI - Biotechnology and bionics
Completed project evaluation
Provider evaluation
U - Uspěl podle zadání (s publikovanými či patentovanými výsledky atd.)
Project results evaluation
The topic of the project and the application of the given protein is very interesting and promising. After solving the fundamental issues, especially of a regulatory, production and financial nature, there is a great potential for a high impact on the company. The recipient has contacted potential partners, has feedback from them and therefore knows what to focus on in the immediate future. The weakness remains the regulatory environment, which is essentially at the beginning in both the EU and the US, but is crucial for the launch of the product itself on the market.
Solution timeline
Realization period - beginning
Oct 1, 2021
Realization period - end
Mar 31, 2022
Project status
U - Finished project
Latest support payment
Feb 28, 2022
Data delivery to CEP
Confidentiality
C - Předmět řešení projektu podléhá obchodnímu tajemství (§ 504 Občanského zákoníku), ale název projektu, cíle projektu a u ukončeného nebo zastaveného projektu zhodnocení výsledku řešení projektu (údaje P03, P04, P15, P19, P29, PN8) dodané do CEP, jsou upraveny tak, aby byly zveřejnitelné.
Data delivery code
CEP23-TA0-TP-U
Data delivery date
Jun 30, 2023
Finance
Total approved costs
938 thou. CZK
Public financial support
516 thou. CZK
Other public sources
0 thou. CZK
Non public and foreign sources
422 thou. CZK
Basic information
Recognised costs
938 CZK thou.
Public support
516 CZK thou.
55%
Provider
Technology Agency of the Czech Republic
OECD FORD
Industrial biotechnology
Solution period
01. 10. 2021 - 31. 03. 2022